397 related articles for article (PubMed ID: 31228675)
1. The effect of administration of intravenous intralipid on pregnancy outcomes in women with implantation failure after IVF/ICSI with non-donor oocytes: A randomised controlled trial.
Singh N; Davis AA; Kumar S; Kriplani A
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():45-51. PubMed ID: 31228675
[TBL] [Abstract][Full Text] [Related]
2. Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial.
Al-Zebeidi J; Agdi M; Lary S; Al-Obaid S; Salim G; Al-Jaroudi D
Gynecol Endocrinol; 2020 Feb; 36(2):131-134. PubMed ID: 31220957
[TBL] [Abstract][Full Text] [Related]
3. Intrauterine administration of hCG immediately after oocyte retrieval and the outcome of ICSI: a randomized controlled trial.
Navali N; Gassemzadeh A; Farzadi L; Abdollahi S; Nouri M; Hamdi K; Mallah F; Jalilvand F
Hum Reprod; 2016 Nov; 31(11):2520-2526. PubMed ID: 27680029
[TBL] [Abstract][Full Text] [Related]
4. The effect of intralipid on pregnancy outcomes in women with previous implantation failure in in vitro fertilization/intracytoplasmic sperm injection cycles: A systematic review and meta-analysis.
Zhou P; Wu H; Lin X; Wang S; Zhang S
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():187-192. PubMed ID: 32622103
[TBL] [Abstract][Full Text] [Related]
5. Endometrial scratching in women with implantation failure after a first IVF/ICSI cycle; does it lead to a higher live birth rate? The SCRaTCH study: a randomized controlled trial (NTR 5342).
van Hoogenhuijze NE; Torrance HL; Mol F; Laven JSE; Scheenjes E; Traas MAF; Janssen C; Cohlen B; Teklenburg G; de Bruin JP; van Oppenraaij R; Maas JWM; Moll E; Fleischer K; van Hooff MH; de Koning C; Cantineau A; Lambalk CB; Verberg M; Nijs M; Manger AP; van Rumste M; van der Voet LF; Preys-Bosman A; Visser J; Brinkhuis E; den Hartog JE; Sluijmer A; Jansen FW; Hermes W; Bandell ML; Pelinck MJ; van Disseldorp J; van Wely M; Smeenk J; Pieterse QD; Boxmeer JC; Groenewoud ER; Eijkemans MJC; Kasius JC; Broekmans FJM
BMC Womens Health; 2017 Jul; 17(1):47. PubMed ID: 28732531
[TBL] [Abstract][Full Text] [Related]
6. Intravenous intralipid therapy is not beneficial in having a live delivery in women aged 40-42 years with a previous history of miscarriage or failure to conceive despite embryo transfer undergoing in vitro fertilization-embryo transfer.
Check JH; Check DL
Clin Exp Obstet Gynecol; 2016; 43(1):14-5. PubMed ID: 27048011
[TBL] [Abstract][Full Text] [Related]
7. Intralipid® may represent a new hope for patients with reproductive failures and simultaneously an over-immune endometrial activation.
Lédée N; Vasseur C; Petitbarat M; Chevrier L; Vezmar K; Dray G; Chenière S; Lobersztajn A; Vitoux D; Cassuto GN; Chaouat G
J Reprod Immunol; 2018 Nov; 130():18-22. PubMed ID: 30286362
[TBL] [Abstract][Full Text] [Related]
8. The role of intracytoplasmic sperm injection in non-male factor infertility in advanced maternal age.
Tannus S; Son WY; Gilman A; Younes G; Shavit T; Dahan MH
Hum Reprod; 2017 Jan; 32(1):119-124. PubMed ID: 27852688
[TBL] [Abstract][Full Text] [Related]
9. The effect of endometrial injury on ongoing pregnancy rate in unselected subfertile women undergoing in vitro fertilization: a randomized controlled trial.
Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
Hum Reprod; 2014 Nov; 29(11):2474-81. PubMed ID: 25205759
[TBL] [Abstract][Full Text] [Related]
10. Oocyte Degeneration After ICSI Is Not an Indicator of Live Birth in Young Women.
Hu X; Liu Y; Zhang X; Lee P; Wen Y; Ding C; Zhou C; Xu Y
Front Endocrinol (Lausanne); 2021; 12():705733. PubMed ID: 34484119
[TBL] [Abstract][Full Text] [Related]
11. Intralipid supplementation in women with recurrent spontaneous abortion and elevated levels of natural killer cells.
Dakhly DM; Bayoumi YA; Sharkawy M; Gad Allah SH; Hassan MA; Gouda HM; Hashem AT; Hatem DL; Ahmed MF; El-Khayat W
Int J Gynaecol Obstet; 2016 Dec; 135(3):324-327. PubMed ID: 27614789
[TBL] [Abstract][Full Text] [Related]
12. Reduced live-birth rates after IVF/ICSI in women with previous unilateral oophorectomy: results of a multicentre cohort study.
Lind T; Holte J; Olofsson JI; Hadziosmanovic N; Gudmundsson J; Nedstrand E; Lood M; Berglund L; Rodriguez-Wallberg K
Hum Reprod; 2018 Feb; 33(2):238-247. PubMed ID: 29211889
[TBL] [Abstract][Full Text] [Related]
13. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
Tournaye H; Sukhikh GT; Kahler E; Griesinger G
Hum Reprod; 2017 May; 32(5):1019-1027. PubMed ID: 28333318
[TBL] [Abstract][Full Text] [Related]
14. Use of donor sperm in addition to oocyte donation after repeated implantation failure in normozoospermic patients does not improve live birth rates.
Blázquez A; García D; Rodríguez A; Vassena R; Vernaeve V
Hum Reprod; 2016 Nov; 31(11):2549-2553. PubMed ID: 27609983
[TBL] [Abstract][Full Text] [Related]
15. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA
Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
[TBL] [Abstract][Full Text] [Related]
16. ICSI does not increase the cumulative live birth rate in non-male factor infertility.
Li Z; Wang AY; Bowman M; Hammarberg K; Farquhar C; Johnson L; Safi N; Sullivan EA
Hum Reprod; 2018 Jul; 33(7):1322-1330. PubMed ID: 29897449
[TBL] [Abstract][Full Text] [Related]
17. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
[TBL] [Abstract][Full Text] [Related]
18. Induced endometrial trauma (endometrial scratch) in the mid-luteal menstrual cycle phase preceding first cycle IVF/ICSI versus usual IVF/ICSI therapy: study protocol for a randomised controlled trial.
Pye C; Chatters R; Cohen J; Brian K; Cheong YC; Laird S; Mohiyiddeen L; Skull J; Walters S; Young T; Metwally M
BMJ Open; 2018 May; 8(5):e020755. PubMed ID: 29780028
[TBL] [Abstract][Full Text] [Related]
19. Impact of the number of previous embryo implantation failures on IVF/ICSI-ET pregnancy outcomes in patients younger than 40 years: a retrospective cohort study.
Fang Y; Jingjing F; Tiantain C; Huanhuan X; Qiaohua H
Front Endocrinol (Lausanne); 2023; 14():1243402. PubMed ID: 37842291
[TBL] [Abstract][Full Text] [Related]
20. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
